Breakfast News: Week in Review

Published August 21, 2026 · Category: Finance

Overview

Investing demands patience, and every so often, there's a week that makes the case for sitting still and doing nothing. On Wednesday, a stock that had disappointed since its COVID pandemic boom days came roaring back on the news of its medical breakthrough, finally rewarding investors. Elsewhere, three businesses we've recommended kept growing their leads by advancing the strategies we believed in. And earnings season marches on, with Nvidia (NASDAQ: NVDA) taking its turn in the spotlight next week.

Source: Image created by Jester AI.

Moderna's (NASDAQ: MRNA) COVID vaccine made a fortune, then orders dried up and the shares drifted for years. Then, on Wednesday, the stock jumped 177% on news of a clinical trial breakthrough. It gave back some gains on Thursday and closed at $133, still double where the week began, though far below its pandemic-era peak.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

• Why I'm Wary of Most Housing Stocks, Except This One
• 6 AI hardware stocks to own for the remainder of the year, according to an analyst
• Stocks making the biggest moves midday: Moderna, Robinhood, BJ's Wholesale, Coinbase & more